Satoshi Kishigami Associate Professor, School of Biology-Oriented Science and Technology, Kinki University

Both somatic cell nuclear transfer (SCNT) and iPS technologies, which reprogram the somatic cell genome to totipotent and pluripotent states, are facing extreme inefficiency as a common problem. In this project, based on the new SCNT technology using histone deacetylase inhibitor we recently developed, I aim to develop a new reprogram-enhancing technology.

Homepage URL:http://www.waka.kindai.ac.jp/gakubu/iden_labo/hasei_iden.html